Clinical-stage immunotherapeutics and vaccines
| Date | Round | Amount |
|---|---|---|
| Mar 2021 | Series B Oxford biopharma Vaccitech (co-inventor of the AstraZeneca COVID vaccine) raised a $168M Series B led by M&G Investment Management, with Tencent, Gilead Sciences and Oxford Sciences Innovation. | $168M |